导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 35.80% | 429/4981 |
| 近一周 | -0.06% | 2046/5421 |
| 近一月 | -4.19% | 1761/5424 |
| 近一季 | -28.61% | 5260/5380 |
| 近半年 | 19.86% | 756/5140 |
| 近一年 | 25.53% | 778/4741 |
| 近两年 | 53.54% | 2162/4207 |
| 近三年 | 17.72% | 2352/3662 |
| 成立以来 | 147.88% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
10.96% 197/5130 |
79.36% 426/5464 |
- - |
- - |
| 2025 | -0.21% 4336/5130 |
-2.89% 4295/4624 |
-6.40% 4508/4802 |
22.46% 2505/4970 |
-10.34% 4483/5130 |
| 2024 | -9.38% 3578/4618 |
-4.27% 2432/4340 |
-6.19% 3356/4442 |
13.01% 1352/4550 |
-10.71% 4340/4618 |
| 2023 | -28.02% 3309/4216 |
-5.09% 3278/3759 |
7.24% 108/3909 |
-22.16% 3821/4055 |
-9.14% 3602/4209 |
| 2022 | -28.96% 2255/3578 |
-20.38% 1996/2804 |
13.52% 465/3205 |
-16.34% 2621/3430 |
-6.05% 2784/3570 |
| 2021 | 43.81% 57/2717 |
-4.77% 971/1745 |
41.55% 16/2232 |
12.76% 151/2560 |
-5.39% 2163/2708 |
| 2020 | 99.83% 34/1596 |
14.12% 25/1036 |
41.47% 23/1256 |
-7.12% 1230/1472 |
33.26% 19/1690 |
| 2019 | 26.22% 590/926 |
25.35% 898/3054 |
-11.44% 2991/3201 |
5.14% 495/939 |
8.15% 530/1014 |
| 2018 | -24.66% 298/668 |
- - |
- - |
- - |
-11.63% 2273/2977 |
| 2017 | 10.65% 277/531 |
- - |
- - |
- - |
- - |
| 2016 | -21.96% 330/455 |
- - |
- - |
- - |
- - |
| 2015 | 43.96% 222/433 |
- - |
- - |
- - |
- - |
| 2014 | 38.06% 74/432 |
- - |
- - |
- - |
- - |
| 2013 | 12.45% 222/398 |
- - |
- - |
- - |
- - |
| 2012 | -7.36% 452/459 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商品质成长混合C | 1.0027 | 56.52% |
| 招商创新增长混合A | 1.0759 | 55.91% |
| 招商创新增长混合C | 1.0235 | 55.61% |
| 招商品质成长混合A | 1.0435 | 55.01% |
| 华泰柏瑞医疗健康A | 2.6422 | 50.99% |
| 华泰柏瑞医疗健康C | 2.5804 | 49.15% |
| 大摩优悦安和混合A | 0.8994 | 48.05% |
| 大摩优悦安和混合C | 0.8828 | 47.91% |
| 中信建投医药健康A | 0.7950 | 39.62% |
| 中信建投医药健康C | 0.7579 | 39.35% |
| 金鹰策略配置混合 VS. 长安宏观策略混合A(740001) |